PurposeMetabolic response to treatment measured by fluorine-18 fluorodeoxyglucose (18F-FDG) PET has prognostic implications in many cancers. This study investigated the association between survival and early changes on 18F-FDG PET/computed tomography (CT) for patients with BRAF-mutant melanoma recei